Novo Nordisk’s weight-loss-drug trial provides rare good news in a rocky year

by | Nov 25, 2025 | Stock Market

Novo Nordisk, whose shares have stumbled this year, on Tuesday announced a positive trial result for a weight-loss drug in development.

Article Attribution | Read More at Article Source